GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and positive results for its Lipid inCode® test (“Lipid inCode®”) for hypercholesterolemia (high levels of cholesterol), including Familial Hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals (“RB&H”), recently merged with […]
The post Positive Results for Lipid inCode® in NHS Clinical Study first appeared on PR Business News Wire.
http://dlvr.it/SK0S7D
No comments:
Post a Comment